Moderna (MRNA.O) surged 100% intraday, pushing its market capitalization above $50 billion, after the company and Merck announced the success of their melanoma vaccine research. Merck (MRK.N) rose 10%, and BioNTech climbed 17.6%.
2026-08-19
Moderna (MRNA.O) surged 100% intraday, pushing its market capitalization above $50 billion, after the company and Merck announced the success of their melanoma vaccine research. Merck (MRK.N) rose 10%, and BioNTech climbed 17.6%.